인쇄하기
취소

Ilsung Pharmaceuticals and Huons made the exclusive sale contract for the arteriosclerosis drug ‘Arigrel’

Published: 2015-05-07 10:31:22
Updated: 2015-05-07 10:31:22

Ilsung Pharmaceuticals (CEO Suk-geun Yoon) and Huons (CEO Jae-gab Jeon) held a signing ceremony of their exclusive sale contract for the arteriosclerosis treatment ‘Arigrel’ on the last 1st.

Under the contract, Arigrel Cap, which is manufactured by Huons, will be supplied through the Ilsung Pharmaceuticals’ wholesale channel.

Through the partnership, Ilsung Pharmaceuticals has now acquired th...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.